Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSDT NASDAQ:LYRA NASDAQ:STRR NASDAQ:TNON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSDTHelius Medical Technologies$8.36+8.4%$93.15$7.15▼$1,200.00$100K0.8638,383 shs67,463 shsLYRALyra Therapeutics$8.53+0.6%$10.05$3.81▼$37.50$11.24M0.24192,279 shs37,300 shsSTRRStar Equity$1.97+0.5%$2.10$1.72▼$5.35$6.29M0.9316,495 shs5,183 shsTNONTenon Medical$1.02$1.03$0.85▼$15.79$7.74M1.222.50 million shs190,021 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSDTHelius Medical Technologies+8.43%-0.83%-55.47%-95.95%-98.70%LYRALyra Therapeutics+0.59%-8.28%-24.71%+97.23%-44.97%STRRStar Equity+0.51%+0.51%-0.51%+7.36%-60.52%TNONTenon Medical0.00%-8.11%+15.62%-8.93%+43.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSDTHelius Medical Technologies0.7604 of 5 stars0.04.00.00.01.80.80.6LYRALyra Therapeutics2.6879 of 5 stars3.22.00.00.02.42.51.3STRRStar Equity3.6191 of 5 stars3.55.00.00.02.71.71.3TNONTenon Medical1.9937 of 5 stars3.53.00.00.03.00.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSDTHelius Medical Technologies 2.00HoldN/AN/ALYRALyra Therapeutics 2.33Hold$100.001,072.33% UpsideSTRRStar Equity 3.00Buy$5.00153.81% UpsideTNONTenon Medical 3.00Buy$4.67357.52% UpsideCurrent Analyst Ratings BreakdownLatest HSDT, STRR, TNON, and LYRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025STRRStar EquityMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $5.005/14/2025TNONTenon MedicalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSDTHelius Medical Technologies$520K0.16N/AN/A$212.95 per share0.04LYRALyra Therapeutics$1.53M7.41N/AN/A$8.86 per share0.96STRRStar Equity$57.17M0.11$0.33 per share6.01$10.98 per share0.18TNONTenon Medical$3.28M2.36N/AN/A$0.71 per share1.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSDTHelius Medical Technologies-$11.74M-$2,376.31N/A∞N/A-3,010.14%-418.82%-243.54%8/11/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)STRRStar Equity-$10.44M-$3.43N/AN/AN/A-16.43%-8.24%-3.48%8/12/2025 (Estimated)TNONTenon Medical-$13.67M-$27.23N/A∞N/A-417.57%-558.92%-129.73%8/11/2025 (Estimated)Latest HSDT, STRR, TNON, and LYRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025LYRALyra Therapeutics-$5.79N/AN/AN/A$0.18 millionN/A8/12/2025Q2 2025STRRStar Equity-$0.26N/AN/AN/A$16.75 millionN/A8/11/2025Q2 2025TNONTenon Medical-$0.47N/AN/AN/A$0.91 millionN/A5/14/2025Q1 2025STRRStar Equity-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million5/13/2025Q1 2025TNONTenon Medical-$1.06-$1.01+$0.05-$1.01$0.76 million$0.73 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 million5/1/2025Q1 2025HSDTHelius Medical Technologies-$29.00-$25.50+$3.50-$0.51N/A$0.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSDTHelius Medical TechnologiesN/A1.691.13LYRALyra TherapeuticsN/A2.962.96STRRStar Equity0.221.420.88TNONTenon MedicalN/A5.465.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSDTHelius Medical Technologies18.63%LYRALyra Therapeutics95.62%STRRStar Equity3.84%TNONTenon Medical22.74%Insider OwnershipCompanyInsider OwnershipHSDTHelius Medical Technologies17.90%LYRALyra Therapeutics3.25%STRRStar Equity33.51%TNONTenon Medical0.33%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSDTHelius Medical Technologies3010,00011,000Not OptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableSTRRStar Equity4603.21 million2.13 millionNot OptionableTNONTenon Medical87.59 million7.57 millionNot OptionableHSDT, STRR, TNON, and LYRA HeadlinesRecent News About These CompaniesTenon Medical (NASDAQ:TNON) Trading Down 1% - Time to Sell?July 16 at 4:27 AM | americanbankingnews.comNASDAQ:TNON Financials | Tenon Medical Inc - Investing.comJuly 11, 2025 | investing.comTenon Medical Inc News (TNON) - Investing.comJuly 9, 2025 | investing.comTNON | Tenon Medical Inc. Annual Cash Flow Statement - MarketWatchJuly 4, 2025 | marketwatch.comTenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar FusionJune 12, 2025 | accessnewswire.comATenon Medical, Inc.: Tenon Medical Reports First Quarter 2025 Financial ResultsMay 14, 2025 | finanznachrichten.deTenon Medical, Inc.: Tenon Medical Reports First Quarter 2025 Financial ResultsMay 14, 2025 | finanznachrichten.deTenon Medical, Inc. (TNON) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comTenon Medical Reports First Quarter 2025 Financial ResultsMay 13, 2025 | accessnewswire.comATenon Medical, Inc. Announces Timing of First Quarter 2025 Financial ResultsApril 29, 2025 | accessnewswire.comAAlliance Global Partners Initiates Coverage of Tenon Medical (TNON) with Buy RecommendationApril 10, 2025 | msn.comTenon Medical initiated with a Buy at Alliance Global PartnersApril 9, 2025 | markets.businessinsider.comTenon Medical files to sell 5.67M shares of common stock for holdersApril 5, 2025 | markets.businessinsider.comTenon gets FDA clearance for Catamaran SI Joint Fusion System indicationMarch 26, 2025 | markets.businessinsider.comTenon Medical prices $2.5M registered direct offering at $2.00March 26, 2025 | markets.businessinsider.comFDA clears Tenon Medical’s Catamaran system expansionMarch 26, 2025 | investing.comTenon Medical dips 6%, prices $2.5M direct offeringMarch 26, 2025 | msn.comTenon Medical earns expanded indication for SI joint fusion systemMarch 25, 2025 | beckersspine.comBTenon Medical Shares Jump After FDA Clears Joint Drug for Broader UseMarch 25, 2025 | marketwatch.comTenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesMarch 25, 2025 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeHSDT, STRR, TNON, and LYRA Company DescriptionsHelius Medical Technologies NASDAQ:HSDT$8.36 +0.65 (+8.43%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$8.38 +0.02 (+0.18%) As of 09:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Lyra Therapeutics NASDAQ:LYRA$8.53 +0.05 (+0.59%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$8.53 0.00 (0.00%) As of 08:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Star Equity NASDAQ:STRR$1.97 +0.01 (+0.51%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.00 +0.03 (+1.52%) As of 08:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.Tenon Medical NASDAQ:TNON$1.02 0.00 (0.00%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.01 -0.01 (-0.98%) As of 09:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
